Precision Toxicilogy
Precision Diagnostics is a privately held clinical laboratory company serving healthcare providers with DNA specimen authentication (VerifID), LC-MS/MS toxicology testing (NextGen), drug interaction checking (DDI), and a virtual waiting room module (UpNEXT), operating from San Diego and Dartmouth.
- Company typePrivate
- Founded2014
- HeadquartersSan Diego, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Precision Toxicilogy does
Precision Diagnostics is a privately held clinical laboratory and diagnostic services company headquartered in San Diego, California, with an additional laboratory facility in Dartmouth, Massachusetts. The company serves healthcare providers — including hospitals, clinics, and medical practices — through a B2B sales-led model focused on toxicology screening, specimen authentication, drug interaction checking, and patient workflow optimization.
The company operates a platform-plus-modules product portfolio across four offerings. VerifID is a DNA matching solution that authenticates urine specimens to the donor patient to verify identity and reduce sample-handling errors. NextGen is a research-grade LC-MS/MS (Liquid Chromatography-Mass Spectrometry/Mass Spectrometry) toxicology testing platform that adjusts cutoff levels to statistically relevant thresholds in patient populations to reduce false negatives. DDI is a drug-to-drug interaction identification platform integrated with Elsevier's Gold Standard Drug Database to flag incompatible medications. UpNEXT is a virtual waiting room module supporting both in-person and telehealth check-in workflows. The company holds CAP (College of American Pathologists) accreditation and CLIA (Clinical Laboratory Improvement Amendments) certification, both required for clinical laboratory operations.
Precision Diagnostics generates revenue through clinical laboratory testing services, structured as recurring subscription or per-test fees paid by healthcare providers. No pricing is publicly disclosed. The company markets principally through its website and LinkedIn, and engages providers through direct sales. There is no public information on funding, headcount, revenue, or named customers.
Precision Toxicilogy firmographics
Firmographics- Name
- Precision Toxicilogy
- Legal name
- Precision Diagnostics
- Website
- https://precisiontoxicology.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Precision Diagnostics is a privately held clinical laboratory company serving healthcare providers with DNA specimen authentication (VerifID), LC-MS/MS toxicology testing (NextGen), drug interaction checking (DDI), and a virtual waiting room module (UpNEXT), operating from San Diego and Dartmouth.
- Ownership category
- akta.pro rank
Precision Toxicilogy industry classification
Industry- Product category
- Clinical Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Reference & Esoteric Testing Laboratories (HLAFAMAJ)
- akta.pro secondary industries
- Diagnostic & Triage Decision Support (HLACAGAA), Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)
Keywords
Where Precision Toxicilogy is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Precision Toxicilogy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Laboratory Testing Services: Diagnostic testing services including DNA verification, toxicology screening, and drug interaction analysis delivered to healthcare providers. Revenue generated through laboratory service fees, likely subscription or per-test pricing models.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Precision Toxicilogy product offering
Product offeringCore offering
Precision Diagnostics is a clinical laboratory service provider that delivers toxicology screening, DNA-based specimen authentication, research-grade LC-MS/MS drug testing, and drug-to-drug interaction analysis to healthcare providers. The company also offers a virtual waiting room (UpNEXT) that streamlines patient check-in for in-person and telehealth visits, sold as part of a diagnostic platform-plus-modules portfolio.
Product overview
Precision Diagnostics offers a platform-plus-modules portfolio of healthcare diagnostic and clinical decision support products. The core offerings include VerifID (DNA specimen authentication), NextGen (LC-MS/MS laboratory testing), and DDI (drug interaction checking), which work together to enhance patient safety and provider efficiency. UpNEXT serves as an add-on virtual waiting room module that integrates with the broader platform to streamline patient check-in experiences for both in-person and telehealth visits.
Differentiator
Problem solved
Functional benefit
Brands
- VerifID: DNA matching solution that verifies patient identity by matching urine specimens to the donor patient.
- NextGen
- UpNEXT
- DDI
Products and services
- VerifID DNA authentication laboratory service that matches a urine specimen to the donor patient, providing infallible identity verification and ensuring precision in sample handling for error-free care. Sold to healthcare providers and clinical organizations.
- NextGen Research-Grade LC-MS/MS toxicology screening service that optimizes cutoff levels to statistically relevant levels in patient populations, providing reliable data for timely clinical interventions and eliminating false negatives common with conventional testing. Sold to healthcare providers.
- UpNEXT Virtual waiting room solution that enhances patient experience by reducing physical wait times, providing real-time updates, and increasing efficiency for healthcare providers through streamlined check-in processes for both in-person and virtual visits. Sold to healthcare providers.
- DDI (Drug-Drug Interaction) Comprehensive drug interaction identification service that helps providers identify drug-to-drug interactions using Elsevier's Gold Standard Drug Database, optimizing therapeutic outcomes and minimizing risk of complications. Sold to healthcare providers.
Quantifiable outcome
- Eliminates false negatives that compromise patient care and undermine trust
Companies that use Precision Toxicilogy
Customer profileSegments1 record
Ideal customer profiles1 record
Precision Toxicilogy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
Precision Toxicilogy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Elsevier (Gold Standard Drug Database)corePrecision's DDI platform integrates with Elsevier's Gold Standard Drug Database to provide comprehensive drug-to-drug interaction identification. This partnership enables healthcare professionals to make informed decisions, optimize therapeutic outcomes, and minimize the risk of adverse drug reactions.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Precision Toxicilogy competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Precision Toxicilogy social profiles
Digital presencePrecision Toxicilogy compliance and trust
Trust signalCompliance2 records
Precision Toxicilogy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Precision Toxicilogy leadership team
Management profileNumber of profiles
Precision Toxicilogy funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Precision Toxicilogy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Precision Toxicilogy
What does Precision Toxicilogy do?
Precision Diagnostics is a clinical laboratory service provider that delivers toxicology screening, DNA-based specimen authentication, research-grade LC-MS/MS drug testing, and drug-to-drug interaction analysis to healthcare providers. The company also offers a virtual waiting room (UpNEXT) that streamlines patient check-in for in-person and telehealth visits, sold as part of a diagnostic platform-plus-modules portfolio.
Is Precision Toxicilogy a public or private company?
Precision Toxicilogy is a private company. It is classified as unknown and is currently operating.
When was Precision Toxicilogy founded?
Precision Toxicilogy was founded in 2014. It employs 501 to 1,000 people.
Where is Precision Toxicilogy based?
Precision Toxicilogy is headquartered in San Diego, United States, in the North America region.
How does Precision Toxicilogy make money?
One revenue line is on record: clinical Laboratory Testing Services.
Does Precision Toxicilogy have an API?
No public API is recorded for Precision Toxicilogy.
What industry is Precision Toxicilogy in?
Precision Toxicilogy's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLACAGAA, Diagnostic & Triage Decision Support. Its NAICS code is 621511 and its SIC code is 8071.